We never wanted to be another cookie-cutter VC at @syndicateroom. We wanted to build a fund from first principles, so we analysed millions of data points.
Want to know what we found? 👇
"MOTH ranked UK’s fastest-growing premium RTD brand just two years after launch"
Congratulations to Access portfolio company MOTH Drinks (https://t.co/si5mCdaj0O) on its meteoric rise: find out more about this inspiring success story below.
https://t.co/MJDL0PjCGf
#EIS and #SEIS both offer a way for investors to reduce their tax bill, but there are key differences between the two schemes. Find out which carries the greater risk in our recent article:
https://t.co/0Qk8qyTJIB
Why do so many investors get ESG wrong?
Listen to the podcast with @SyndicateRoom's @tombritton & @hkleach, Co-Founder of VentureESG.
https://t.co/LFTCzE3nwm
Two days left until tax year end! The new financial year end will see some significant changes to tax thresholds that could affect the amount of tax you pay.
https://t.co/czgEi1Oy0X
Risk Warning: Don’t invest unless you’re prepared to lose all the money you invest.
Hardman publication: #SyndicateRoom - Access EIS Fund
The Access EIS Fund is an Alternative Investment Fund, which will provide a portfolio of investments in high-growth British companies, investing alongside angel investors.
Read here: https://t.co/q1ISBiSVgz
@SyndicateRoom
I love @SyndicateRoom data driven white papers, so it was great to get @GSchwikk on to discuss their latest one on the #power law. It has some interesting, and slightly counter-intuitive, consequences for investors and how they should build their portfolios. A great discussion
There’s only one person who loves an end of year bonus more than you. And that’s HMRC.
If you’d prefer to pay less tax, invest in Access EIS and claim back 30% of your income tax.
Find out more https://t.co/9nDDRhzT0n
#capitalatrisk
Beeline has created a smart compass and app system that guides cyclists and motorcyclists to their destination
Our fund backed @ridebeeline in June 2022, co-investing with one of our market-beating angel investors.
Find out more:
https://t.co/9nDDRhRuoX
#capitalatrisk
Clerkenwell Health partners with psychedelic drug developers to bring life-changing mental health treatments to patients.
Our fund backed @clerkenwell_uk in June 2022, co-investing with one of our market-beating angel investors.
https://t.co/9nDDRhRuoX
#capitalatrisk
What can investors today learn from startups founded during the great recession?
Read the article by @SyndicateRoom CEO, @GSchwikk:
https://t.co/R35eI7CrtN
@fdestin@emollick I think you could look at funding history, cap table make up (previous investors and co investors), accelerator attendance, grants received. All of that is available at the market level in the UK for a more detailed analysis that we try run.
Tax isn't going anywhere, but there are ways to make sure your investments are as tax-efficient as possible. Here are a few of the options out there:
Read the article: https://t.co/rTSiSpTnLk
#eis#seis#capitalatrisk#taxefficient#investing
How can we use the Access Fund algorithms to analyse investment into the UK AI startup market? Watch the presentation by @SyndicateRoom CEO, @GSchwikk.
https://t.co/xiYK8naw29
A huge shoutout and thank you to our partner for the Female Newcomer Founder Award Female Innovation @SyndicateRoom , you make this event possible! 🥳🎉🎉🎉🎉🤝🤝
How has COVID-19 affected EIS investing? Last month, HMRC published its annual EIS data and we finally got a look at how EIS fundraising changed in 2020.
Read the article: https://t.co/v32cPAbkzo
#ukstartups#capitalatrisk
Terminator won't come after VC jobs any time soon... But AI and Deep Tech are changing the way the world works.
We heard from @francesco_srv who invests in these technologies and @GSchwikk that uses big data to source deals, moderated by @Pakhomenka